Lifestyle Drugs

Global Market Trajectory & Analytics

MCP13016

EXECUTIVE ENGAGEMENTS

OUTREACH

8432
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1182
Interactions with Platform & by Email

PARTICIPANTS

253
Unique # Participated

VALIDATIONS

114
Responses Validated*

COMPETITORS

38
Responses Validated*

BRANDS

0
Responses Validated*
* Login for a full stack data experience

DATE

JUL 2020

TABLES

60

PAGES

128

EDITION

7

PRICE

USD $4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Lifestyle Drugs estimated at US$30.7 Billion in the year 2020, is projected to reach a revised size of US$37.2 Billion by 2027, growing at a CAGR of 2.8% over the analysis period 2020-2027. Depression, one of the segments analyzed in the report, is projected to record a 2.4% CAGR and reach US$8.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Dermatology segment is readjusted to a revised 2.6% CAGR for the next 7-year period.
The Lifestyle Drugs market in the U.S. is estimated at US$9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2027 trailing a CAGR of 2.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 2.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.
In the global Sexual Dysfunction segment, USA, Canada, Japan, China and Europe will drive the 2.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.8 Billion in the year 2020 will reach a projected size of US$3.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.2 Billion by the year 2027.We bring years of research experience to this 7th edition of our report. The 128-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

SELECT PLAYERS

Alembic Pharmaceuticals Limited; Amgen, Inc.; AstraZeneca PLC; Biocon Ltd.; Cipla Ltd.; Dr. Reddy's Laboratories Ltd.; Eli Lilly and Company; GlaxoSmithKline PLC; Johnson & Johnson; Lupin Ltd.; Merck & Co., Inc.; Mylan Pharmaceuticals, Inc.; Novo Nordisk A/S; Pfizer, Inc.; Piramal Enterprises Limited; Procter & Gamble Company, The; Sun Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.; Zydus Cadila

SEGMENTS

» Therapy Area (Depression, Dermatology, Sexual Dysfunction, Obesity)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Global Competitor Market Shares
Lifestyle Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Lifestyle Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
Lifestyle Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
Lifestyle Drugs Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
Depression (Therapy Area) World Market by Region/Country in US$ Million: 2020 to 2027
Depression (Therapy Area) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
Depression (Therapy Area) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Dermatology (Therapy Area) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Dermatology (Therapy Area) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
Dermatology (Therapy Area) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Sexual Dysfunction (Therapy Area) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Sexual Dysfunction (Therapy Area) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
Sexual Dysfunction (Therapy Area) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Obesity (Therapy Area) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Obesity (Therapy Area) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
Obesity (Therapy Area) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Lifestyle Drugs Market Share (in %) by Company: 2019 & 2025
United States Lifestyle Drugs Market Estimates and Projections in US$ Million by Therapy Area: 2020 to 2027
Lifestyle Drugs Market in the United States by Therapy Area: A Historic Review in US$ Million for 2012-2019
United States Lifestyle Drugs Market Share Breakdown by Therapy Area: 2012 VS 2020 VS 2027
CANADA
Canadian Lifestyle Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2020 to 2027
Canadian Lifestyle Drugs Historic Market Review by Therapy Area in US$ Million: 2012-2019
Lifestyle Drugs Market in Canada: Percentage Share Breakdown of Sales by Therapy Area for 2012, 2020, and 2027
JAPAN
Japanese Market for Lifestyle Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy Area for the Period 2020-2027
Lifestyle Drugs Market in Japan: Historic Sales Analysis in US$ Million by Therapy Area for the Period 2012-2019
Japanese Lifestyle Drugs Market Share Analysis by Therapy Area: 2012 VS 2020 VS 2027
CHINA
Chinese Lifestyle Drugs Market Growth Prospects in US$ Million by Therapy Area for the Period 2020-2027
Lifestyle Drugs Historic Market Analysis in China in US$ Million by Therapy Area: 2012-2019
Chinese Lifestyle Drugs Market by Therapy Area: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Lifestyle Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Lifestyle Drugs Market Demand Scenario in US$ Million by Region/Country: 2020-2027
Lifestyle Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
European Lifestyle Drugs Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
European Lifestyle Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2020-2027
Lifestyle Drugs Market in Europe in US$ Million by Therapy Area: A Historic Review for the Period 2012-2019
European Lifestyle Drugs Market Share Breakdown by Therapy Area: 2012 VS 2020 VS 2027
FRANCE
Lifestyle Drugs Market in France by Therapy Area: Estimates and Projections in US$ Million for the Period 2020-2027
French Lifestyle Drugs Historic Market Scenario in US$ Million by Therapy Area: 2012-2019
French Lifestyle Drugs Market Share Analysis by Therapy Area: 2012 VS 2020 VS 2027
GERMANY
Lifestyle Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy Area for the Period 2020-2027
German Lifestyle Drugs Historic Market Analysis in US$ Million by Therapy Area: 2012-2019
German Lifestyle Drugs Market Share Breakdown by Therapy Area: 2012 VS 2020 VS 2027
ITALY
Italian Lifestyle Drugs Market Growth Prospects in US$ Million by Therapy Area for the Period 2020-2027
Lifestyle Drugs Historic Market Analysis in Italy in US$ Million by Therapy Area: 2012-2019
Italian Lifestyle Drugs Market by Therapy Area: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
United Kingdom Market for Lifestyle Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy Area for the Period 2020-2027
Lifestyle Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy Area for the Period 2012-2019
United Kingdom Lifestyle Drugs Market Share Analysis by Therapy Area: 2012 VS 2020 VS 2027
REST OF EUROPE
Rest of Europe Lifestyle Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2020-2027
Lifestyle Drugs Market in Rest of Europe in US$ Million by Therapy Area: A Historic Review for the Period 2012-2019
Rest of Europe Lifestyle Drugs Market Share Breakdown by Therapy Area: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Lifestyle Drugs Market in Asia-Pacific by Therapy Area: Estimates and Projections in US$ Million for the Period 2020-2027
Asia-Pacific Lifestyle Drugs Historic Market Scenario in US$ Million by Therapy Area: 2012-2019
Asia-Pacific Lifestyle Drugs Market Share Analysis by Therapy Area: 2012 VS 2020 VS 2027
REST OF WORLD
Rest of World Lifestyle Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2020 to 2027
Rest of World Lifestyle Drugs Historic Market Review by Therapy Area in US$ Million: 2012-2019
Lifestyle Drugs Market in Rest of World: Percentage Share Breakdown of Sales by Therapy Area for 2012, 2020, and 2027
Total Companies Profiled: 38

General queries: Info411@StrategyR.com